Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9518123 Compositions and methods for treatment of cancer

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Carl H. June0

Bruce L. Levine0

David L. Porter0

Michael C. Milone0

Michael D. Kalos0

Date of Patent

December 13, 2016

0

Patent Application Number

149970420

Date Filed

January 15, 2016

0

Patent Citations Received

US Patent 11944648 Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

0

US Patent 12076375 Treating and preventing

0

0

US Patent 11680103 Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

0

US Patent 11697825 Compositions and methods for the production of scAAV

0

US Patent 11701384 Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments

0

US Patent 11759480 Compositions and methods for CAR T cell therapy

US Patent 11952428 BCMA chimeric antigen receptors and uses thereof

0

...

Patent Primary Examiner

Michael Burkhart

0

Patent abstract

The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9518123 Compositions and methods for treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool